These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 9795766)
1. Myelin protein expression in lymphoid tissues: implications for peripheral tolerance. Voskuhl RR Immunol Rev; 1998 Aug; 164():81-92. PubMed ID: 9795766 [TBL] [Abstract][Full Text] [Related]
2. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809 [TBL] [Abstract][Full Text] [Related]
3. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658 [TBL] [Abstract][Full Text] [Related]
4. Epitope spreading occurs in active but not passive EAE induced by myelin basic protein. Voskuhl RR; Farris RW; Nagasato K; McFarland HF; Dalcq MD J Neuroimmunol; 1996 Nov; 70(2):103-11. PubMed ID: 8898718 [TBL] [Abstract][Full Text] [Related]
5. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Kerlero de Rosbo N; Mendel I; Ben-Nun A Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302 [TBL] [Abstract][Full Text] [Related]
6. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. Yu M; Johnson JM; Tuohy VK J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934 [TBL] [Abstract][Full Text] [Related]
7. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. McRae BL; Kennedy MK; Tan LJ; Dal Canto MC; Picha KS; Miller SD J Neuroimmunol; 1992 Jun; 38(3):229-40. PubMed ID: 1376328 [TBL] [Abstract][Full Text] [Related]
8. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788 [TBL] [Abstract][Full Text] [Related]
9. Male SJL mice do not relapse after induction of EAE with PLP 139-151. Bebo BF; Vandenbark AA; Offner H J Neurosci Res; 1996 Sep; 45(6):680-9. PubMed ID: 8892079 [TBL] [Abstract][Full Text] [Related]
10. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread. Takács K; Chandler P; Altmann DM Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820 [TBL] [Abstract][Full Text] [Related]
11. Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response. Kuerten S; Schickel A; Kerkloh C; Recks MS; Addicks K; Ruddle NH; Lehmann PV Acta Neuropathol; 2012 Dec; 124(6):861-73. PubMed ID: 22842876 [TBL] [Abstract][Full Text] [Related]
12. T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis. Perry LL; Barzaga-Gilbert E; Trotter JL J Neuroimmunol; 1991 Jul; 33(1):7-15. PubMed ID: 1711539 [TBL] [Abstract][Full Text] [Related]
13. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel RP J Exp Med; 1999 Apr; 189(7):1033-42. PubMed ID: 10190894 [TBL] [Abstract][Full Text] [Related]
14. The immune response to a subdominant epitope in myelin basic protein exon-2 results in immunity to intra- and intermolecular dominant epitopes. Zhao ML; Fritz RB J Neuroimmunol; 1995 Sep; 61(2):179-84. PubMed ID: 7593553 [TBL] [Abstract][Full Text] [Related]
15. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice. Whitham RH; Jones RE; Hashim GA; Hoy CM; Wang RY; Vandenbark AA; Offner H J Immunol; 1991 Dec; 147(11):3803-8. PubMed ID: 1719089 [TBL] [Abstract][Full Text] [Related]
16. Myelin protein expression is increased in lymph nodes of mice with relapsing experimental autoimmune encephalomyelitis. MacKenzie-Graham AJ; Pribyl TM; Kim S; Porter VR; Campagnoni AT; Voskuhl RR J Immunol; 1997 Nov; 159(9):4602-10. PubMed ID: 9379062 [TBL] [Abstract][Full Text] [Related]
17. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Vanderlugt CL; Begolka WS; Neville KL; Katz-Levy Y; Howard LM; Eagar TN; Bluestone JA; Miller SD Immunol Rev; 1998 Aug; 164():63-72. PubMed ID: 9795764 [TBL] [Abstract][Full Text] [Related]
18. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice. Kono DH; Urban JL; Horvath SJ; Ando DG; Saavedra RA; Hood L J Exp Med; 1988 Jul; 168(1):213-27. PubMed ID: 2456367 [TBL] [Abstract][Full Text] [Related]
19. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis. Yu M; Johnson JM; Tuohy VK J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907 [TBL] [Abstract][Full Text] [Related]
20. Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides. Kuchroo VK; Sobel RA; Yamamura T; Greenfield E; Dorf ME; Lees MB Pathobiology; 1991; 59(5):305-12. PubMed ID: 1716908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]